During the past 10 to 20 years it has become increasingly clear that a certain number of drugs may lead to increased vitamin requirements. However, it is unusual for symptomatic avitaminosis to develop, and then only when circumstances are present which in themselves increase the risk of vitamin deficiency.
Therapeutic doses of drugs will interfere with the vitamin status only to a restricted degree, provided they are administered for brief periods and to patients receiving a normal supply of vitamins. Most cases of vitamin deficiency have in fact been described in connection with drugs usually taken for a longer period of time by patients who were already in negative vitamin balance as a result of disease or marginal supply of the necessary vitamins. This review describes some of the more important articles covering this topic.
KeywordsOral Contraceptive Isoniazid Osteomalacia Pyrimethamine Vitamin Deficiency
Unable to display preview. Download preview PDF.
- Adams, P.W.; Rose, D.P.; Folkard, J.; Seed, M. and Strong, R.: Effect of pyridoxine hydrochloride (vitamin ?6) upon depression associated with oral contraception. Lancet 1: 897–904 (1973).Google Scholar
- Briggs, M.H. and Briggs, M.: Ascorbic acid and the pill. Chemistry in Britain 11: 74 (1975b).Google Scholar
- Cobum, J.W.; Hartenbower, D.L. and Brickman, A.S.: Advances in vitamin D metabolism as they pertain to chronic renal disease. American Journal of Clinical Nutrition 29: 1283–1299 (1976).Google Scholar
- Coronato, A. and Glass, G.B.J.: Depression of the intestinal uptake of radio-vitamin B12 by cholestyramine. Proceedings of the Society of Experimental Biology and Medicine 142: 1341–1344 (1973).Google Scholar
- DaCosta, M. and Rothenberg, S.P.: Appearance of a folate binder in leukocytes and serum of women who are pregnant or taking oral contraceptives. Journal of Laboratory and Clinical Medicine 83: 207–214 (1974).Google Scholar
- Dietrich, L.S.: Regulation of nicotinamide metabolism. American Journal of Clinical Nutrition 24: 800–804 (1971).Google Scholar
- Fingl, E.: Laxatives and cathartics; in Goodman and Gilman (Eds) The Pharmacological Basis of Therapeutics, p.978 (MacMillan Publishing Co. Inc.; New York 1975).Google Scholar
- Gershoff, S.N.: Vitamin B6; in Present Knowledge in Nutrition, pp. 141–161 (The Nutrition Foundation Inc.; New York, Washington 1976).Google Scholar
- Haghshenass, M. and Dodda, B.: Serum folate levels during anticonvulsant therapy with diphenylhydantoin. Journal of the American Geriatric Society 21: 275–277 (1973).Google Scholar
- Hahn, T.J.; Hendin, B.A.; Scharp, C.R.; Boisseau, V.C. and Haddad, J.G.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy. New England Journal of Medicine 292: 550–554 (1975).Google Scholar
- Hollander, D.: Vitamin K1 absorption by everted intestinal sacs of the rat. American Journal of Physiology 226: 360–364 (1973).Google Scholar
- Jaffe, I.A.: Antivitamin B6 effect of D-penicillamine. Annals New York Academy of Sciences 166: 57–60 (1969).Google Scholar
- Johnson, K.G.; Greenen, J.E.; Hensley, G.T. and Soergel, K.H.: Small intestinal disease, folate deficiency anemia, and oral contraceptive agents. Digestive Diseases 18: 185–190 (1973).Google Scholar
- Mason, M.; Ford, J. and Wu, H.L.C.: Effects of steroid and nonsteroid metabolites on enzyme conformation and pyridoxal phosphate binding. Annals of New York Academy of Sciences 166: 170–183 (1969).Google Scholar
- Meulengracht, E.: Osteomalacia of the spinal column from deficient diet or from disease of the digestive tract. III. Osteomalacia e abuse laxantium. Acta Medica Scandinavica 101: 187–210 (1939).Google Scholar
- Pylypchuk, G; Oreopoulos, D.G; Wilson, D.R.; Harrison, J.E.; McNeill, K.G; Melma, H.E.; Ogilvie, R.; Sturbridge, W.C and Murray, T.M.: Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy. Canadian Medical Association Journal 118: 635–638 (1978).PubMedGoogle Scholar
- Reynolds, E.H.; Milner, G; Matthews, D.M. and Chanarin, I.: Anticonvulsant therapy, megaloblastic haemopoiesis and folic acid metabolism. Q. J. Med. 35: 521–537 (1966).Google Scholar
- Sahud, M.A.: Uptake and reduction of dehydroascorbic acid in human platelets. Clinical Research 18: 133 (1970).Google Scholar
- Saroja, N.; Mallikarjuneswara, V.R. and Clemetson, C.A.B.: Effect of estrogens on ascorbic acid in the plasma and blood vessels of guinea pigs. Contraception 3: 269–277 (1971).Google Scholar
- Schmid, F.: Osteopathien bei antiepileptischer Dauerbehandlung. Fortschritte der Medizin 85: 381–383 (1967).Google Scholar